The issue of bacterial infections in COVID-19 patients has received increasing attention
among scientists. Antibiotics were widely prescribed during the early phase of the pandemic …

Abstract Background: COVID-19–related acute illness is associated with an increased risk of
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …

There was important heterogeneity in the retrieved literature on the epidemiology of MRSA
lung infection in patients with COVID-19, both when considering all other bacteria as the …

The pandemic caused by the COVID-19 virus has required major adjustments to healthcare
systems, especially to infection control and antimicrobial stewardship. The objective of this …

Two years have passed since WHO declared a pandemic state for SARS-CoV-2 infection.
COVID-19 pathogenesis consists of a first viral phase responsible for early symptoms …

Introduction Currently, several antibiotics are active against methicillin-resistant
Staphylococcus aureus (MRSA) and can be used for the treatment of pneumonia. They …

Background Acute respiratory distress syndrome (ARDS) is one of the most severe
complications of SARS-CoV-2 infection. Non-Invasive Respiratory Support (NRS) as …

COVID-19 spread in two pandemic waves in Italy between 2020 and 2021. The aim of this
study is to compare the first with the second COVID-19 wave, analyzing modifiable and non …

Introduction Excessive use of antibiotics has been frequently reported in hospitalized
patients with COVID-19 worldwide, compared to the actual number of bacterial co-infections …

Since the first identification in December of 2019 and the fast spread of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, it has represented a dramatic …